Literature DB >> 21952319

Preliminary results of conformal computed tomography (CT)-based intracavitary brachytherapy (ICBT) for locally advanced cervical cancer: a single institution's experience.

Ekkasit Tharavichitkul1, Somvilai Mayurasakorn, Vicharn Lorvidhaya, Vimol Sukthomya, Somsak Wanwilairat, Sanchai Lookaew, Nantaka Pukanhaphan, Imjai Chitapanarux, Razvan Galalae.   

Abstract

Intracavitary brachytherapy using tandem and ovoids is an important component of definitive treatment for cervical cancer. In the present study, we analyzed the dose-volume histograms (DVHs) of the tumor volume and organs at risk including the sigmoid colon by CT-based treatment planning for high dose rate (HDR) intracavitary brachytherapy (ICBT) in cervical cancer. Seventeen patients with carcinoma of the cervix uteri were treated with external beam radiotherapy plus concurrent chemotherapy. For brachytherapy, the planning procedure started by performing a conventional plan which prescribed a dose of 6.5-7 Gy per fraction to point A, then optimized the dose based on CT imaging. Volumes and DVHs were calculated for the HR-CTV, bladder, rectum and sigmoid colon. The mean BED(2Gy) total doses of post-optimized plans of HR-CTV, bladder, rectum and sigmoid colon were: 89.6, 94.1, 74.0 and 69.8 Gy, respectively. For conventional plans, the calculated mean BED(2Gy) total doses of HR-CTV, bladder, rectum and sigmoid colon were 92.2, 120.1, 75.7 and 78.3 Gy, respectively. This study showed statistical significant higher BED(2Gy) total doses for bladder and sigmoid colon (p < 0.001) using conventional plans versus post-optimized, CT-based plans, while no difference between HR-CTV and rectum BED(2Gy) total doses could be detected. After a median follow-up of nineteen months, all seventeen patients had a clinical complete response. Two patients developed distant metastasis. Compared with conventional treatment, CT based brachytherapy planning was very effective in reducing doses to OARs, especially bladder and sigmoid colon whilst maintaining a high therapeutic dose for tumor target volumes in the treatment of cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952319     DOI: 10.1269/jrr.10154

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  6 in total

Review 1.  University Cooperation Platform (UCP) between Christian-Albrechts-University Kiel (Germany) and Chiang Mai University (Thailand): implementation of image-guided gynecological brachytherapy.

Authors:  Razvan Galalae; Ekkasit Tharavichitkul; Somsak Wanwilairat; Imjai Chitapanarux; Bernhard Kimmig; Jürgen Dunst; Vicharn Lorvidhaya
Journal:  J Contemp Brachytherapy       Date:  2015-03-05

2.  Survival outcome of cervical cancer patients treated by image-guided brachytherapy: a 'real world' single center experience in Thailand from 2008 to 2018.

Authors:  Ekkasit Tharavichitkul; Bongkot Jia-Mahasap; Pooriwat Muangwong; Somvilai Chakrabandhu; Pitchayaponne Klunklin; Wimrak Onchan; Damrongsak Tippanya; Wannapa Nobnop; Anirut Watcharawipha; Kittikun Kittidachanan; Ravan M Galalae; Imjai Chitapanarux
Journal:  J Radiat Res       Date:  2022-07-19       Impact factor: 2.438

3.  Image-guided brachytherapy (IGBT) combined with whole pelvic intensity-modulated radiotherapy (WP-IMRT) for locally advanced cervical cancer: a prospective study from Chiang Mai University Hospital, Thailand.

Authors:  Ekkasit Tharavichitkul; Somsak Wanwilairat; Somvilai Chakrabandhu; Pitchayaponne Klunklin; Wimrak Onchan; Damrongsak Tippanya; Wannapa Nopnop; Razvan Galalae; Imjai Chitapanarux
Journal:  J Contemp Brachytherapy       Date:  2013-03-29

4.  Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer.

Authors:  Juan Ren; Wei Yuan; Ruihua Wang; Qiuping Wang; Yi Li; Chaofan Xue; Yanli Yan; Xiaowei Ma; Li Tan; Zi Liu
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

5.  Late rectal toxicity determined by dose-volume parameters in computed tomography-based brachytherapy for locally advanced cervical cancer.

Authors:  Yong-Chun Zhou; Li-Na Zhao; Ning Wang; Jing Hu; Xiao-Huan Sun; Ying Zhang; Jian-Ping Li; Wei-Wei Li; Jun-Yue Liu; Li-Chun Wei; Mei Shi
Journal:  Cancer Med       Date:  2016-01-24       Impact factor: 4.452

6.  Who Really Benefits from 3D-Based Planning of Brachytherapy for Cervical Cancer?

Authors:  In Bong Ha; Bae Kwon Jeong; Ki Mun Kang; Hojin Jeong; Yun Hee Lee; Hoon Sik Choi; Jong Hak Lee; Won Jun Choi; Jeong Kyu Shin; Jin Ho Song
Journal:  J Korean Med Sci       Date:  2018-04-13       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.